ARCHIVES

Review Group Report: NCI Role In Drug Development Seen As Information Provider

This article is from The Cancer Letter archive.

Vol. 24 No. 42 | November 6, 1998

Download PDF Visit The Full Archive

Related Articles

In Brief: Congress Recesses With No More Action On Waxman Bill; BCTF to Look at New Diagnosis, Detection

August 12, 1983

Risk Assessment Program Turns 30: Fox Chase Program Helps People Understand Genetic Risks for Cancer

October 25, 2021

Researchers Plan to Extend Phase IIa Asonep Trial

August 29, 2014

Project Enlists PC Users In Quest For Cancer Drugs.

April 6, 2001

Gastrointestinal SPORE To Be Recompeted

June 23, 1995

ACS Journal Cancer Refers I-ELCAP Studies to Office of Human Research Protections

January 6, 2012